Absci (ABSI) Retained Earnings (2020 - 2026)
Absci (ABSI) posted Retained Earnings of -$654.4 million for Q1 2026, down 110824.7% sequentially from $591000.0 in Q4 2025, and down 3444221.05% YoY from N/an in Q1 2025.
Absci (ABSI) Retained Earnings (2020 - 2026) Analysis & Trends
Absci has reported Retained Earnings for 7 years, with the latest figure at -$654.4 million in Q1 2026.
- Quarterly Retained Earnings fell 3444221.05% year-over-year to -$654.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$654.4 million (down 3444221.05% YoY) and the FY2025 annual result came in at $591000.0, up 100.12% from the prior year.
- Retained Earnings retreated to -$654.4 million in Q1 2026 per ABSI's latest filing, from $591000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $591000.0 in Q4 2025 and troughed at -$654.4 million in Q1 2026.
- A 5-year average of -$153.1 million and a median of -$114000.0 in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2026: Retained Earnings surged 525.42% in 2024, then tumbled 3444221.05% in 2026.
- Over 5 years, Retained Earnings stood at -$120000.0 in 2022, then jumped by 69.17% to -$37000.0 in 2023, then plunged by 1377200.0% to -$509.6 million in 2024, then jumped by 100.12% to $591000.0 in 2025, then plunged by 110824.7% to -$654.4 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$654.4 million, $591000.0, and -$595.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | -687.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -687.59 Mn |
| Mar 31, 2026 | -654.38 Mn |
| Dec 31, 2025 | 591,000.00 |
| Sep 30, 2025 | -595.22 Mn |
| Jun 30, 2025 | -566.52 Mn |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | -509.60 Mn |
| Sep 30, 2024 | 251,000.00 |
| Jun 30, 2024 | -114,000.00 |
| Mar 31, 2024 | -132,000.00 |
| Dec 31, 2023 | -37,000.00 |
| Sep 30, 2023 | -59,000.00 |
| Jun 30, 2023 | -146,000.00 |
| Mar 31, 2023 | -95,000.00 |
| Dec 31, 2022 | -120,000.00 |
| Sep 30, 2022 | -276.46 Mn |
| Jun 30, 2022 | -61,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -191.03 Mn |
| Sep 30, 2021 | -165.86 Mn |